MA40858A - Composés antagonistes des récepteurs d3 à la dopamine - Google Patents
Composés antagonistes des récepteurs d3 à la dopamineInfo
- Publication number
- MA40858A MA40858A MA040858A MA40858A MA40858A MA 40858 A MA40858 A MA 40858A MA 040858 A MA040858 A MA 040858A MA 40858 A MA40858 A MA 40858A MA 40858 A MA40858 A MA 40858A
- Authority
- MA
- Morocco
- Prior art keywords
- dopamine
- receptor antagonist
- antagonist compounds
- compounds
- receptor
- Prior art date
Links
- 229940088353 Dopamine D3 receptor antagonist Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000002300 dopamine 3 receptor blocking agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/54—Spiro-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1419433.6A GB201419433D0 (en) | 2014-10-31 | 2014-10-31 | Dopamine D3 receptor antagonist compounds |
GBGB1419430.2A GB201419430D0 (en) | 2014-10-31 | 2014-10-31 | Dopamine D3 receptor antagonist compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MA40858A true MA40858A (fr) | 2021-03-31 |
Family
ID=54427799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA040858A MA40858A (fr) | 2014-10-31 | 2015-10-30 | Composés antagonistes des récepteurs d3 à la dopamine |
Country Status (17)
Country | Link |
---|---|
US (3) | US10000477B2 (fr) |
EP (1) | EP3212637B1 (fr) |
JP (1) | JP2017532364A (fr) |
KR (1) | KR20170090422A (fr) |
CN (1) | CN107108597B (fr) |
AU (1) | AU2015340308B2 (fr) |
CA (1) | CA2964103C (fr) |
DK (1) | DK3212637T3 (fr) |
ES (1) | ES2883831T3 (fr) |
IL (2) | IL251725B (fr) |
MA (1) | MA40858A (fr) |
MX (1) | MX2017005484A (fr) |
NZ (1) | NZ731118A (fr) |
RU (1) | RU2017118562A (fr) |
SG (1) | SG11201702982UA (fr) |
WO (1) | WO2016067043A1 (fr) |
ZA (1) | ZA201702765B (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170090422A (ko) * | 2014-10-31 | 2017-08-07 | 인디비어 유케이 리미티드 | 도파민 d3 수용체 길항제 화합물 |
CN106883192B (zh) * | 2017-03-30 | 2019-05-14 | 苏州汉德创宏生化科技有限公司 | 含氮类杂环抗肿瘤药物活性物恶唑基修饰的苯甲酸类化合物的合成方法 |
WO2019146740A1 (fr) | 2018-01-26 | 2019-08-01 | 塩野義製薬株式会社 | Composé cyclique présentant un antagonisme au récepteur d3 de la dopamine |
TWI767148B (zh) * | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
US11485742B2 (en) | 2019-10-09 | 2022-11-01 | Novartis Ag | 2-azaspiro[3.4]octane derivatives as M4 agonists |
PE20221453A1 (es) | 2019-10-09 | 2022-09-21 | Novartis Ag | Derivados de 2-azaspiro[3,4]octano como agonistas de m4 |
CN110981795B (zh) * | 2019-12-18 | 2021-02-12 | 武汉世纪久海检测技术有限公司 | 一种利用2-氰基异烟酸甲酯制备2-氨酰基异烟酸的方法 |
WO2021127333A1 (fr) * | 2019-12-19 | 2021-06-24 | Casma Therapeutics, Inc. | Modulateurs de trpml |
CN116120213A (zh) * | 2021-06-11 | 2023-05-16 | 重庆医药高等专科学校 | 反式4-(叔丁氧羰氨基)环己烷羧酸的合成方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3654305A (en) * | 1970-01-26 | 1972-04-04 | Robins Co Inc A H | 5-azaspiro(2.4)heptanes |
CA2071897A1 (fr) | 1989-12-28 | 1991-06-29 | Richard A. Glennon | Ligands du recepteur sigma et leur utilisation |
EP0591426A4 (en) | 1991-06-27 | 1996-08-21 | Univ Virginia Commonwealth | Sigma receptor ligands and the use thereof |
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
AU7314200A (en) | 1999-09-17 | 2001-04-24 | Yamanouchi Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
WO2001044193A1 (fr) | 1999-12-16 | 2001-06-21 | Biostream Therapeutics | Analogues de piperidine 1,3,4-substituee et leurs utilisations dans le traitement de la toxicomanie |
MY145722A (en) | 2000-04-27 | 2012-03-30 | Abbott Lab | Diazabicyclic central nervous system active agents |
AU2003228674A1 (en) * | 2002-04-26 | 2003-11-10 | Schering Corporation | Muscarinic antagonists |
EP1802601A1 (fr) | 2004-09-20 | 2007-07-04 | Targacept, Inc. | Composes d'azaspiroalcene et d'azaspiroalcane a activite de recepteurs nicotiniques cholinergiques |
GB0502509D0 (en) | 2005-02-07 | 2005-03-16 | Pfizer Ltd | Novel salt form of a dopamine agonist |
US7977346B2 (en) | 2006-01-17 | 2011-07-12 | Guoqing Paul Chen | Spiro compounds and methods of use |
MX2008011016A (es) | 2006-03-01 | 2008-09-08 | Esteve Labor Dr | Inhibidores de receptor sigma. |
TW200813051A (en) * | 2006-05-08 | 2008-03-16 | Neurogen Corp | Substituted azaspiro derivatives |
US20080247964A1 (en) | 2006-05-08 | 2008-10-09 | Yuelian Xu | Substituted azaspiro derivatives |
GB0700786D0 (en) | 2007-01-15 | 2007-02-21 | Pfizer Ltd | Morpholine dopamine agonists for the treatment of pain |
GB201004200D0 (en) | 2010-03-15 | 2010-04-28 | Univ Basel | Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
WO2012128582A2 (fr) | 2011-03-23 | 2012-09-27 | Hyundai Pharm Co., Ltd. | Composé capable d'inhiber la 11-bêta-hydroxystéroïde déshydrogénase de type 1 humaine et composition pharmaceutique en contenant |
US8809552B2 (en) | 2011-11-01 | 2014-08-19 | Hoffmann-La Roche Inc. | Azetidine compounds, compositions and methods of use |
TWI577671B (zh) | 2011-11-14 | 2017-04-11 | Sunshine Lake Pharma Co Ltd | Aminoquinazoline derivatives and salts thereof and methods of use thereof |
ITMI20112329A1 (it) * | 2011-12-21 | 2013-06-22 | Rottapharm Spa | Nuovi derivati spiro amminici |
KR20170090422A (ko) * | 2014-10-31 | 2017-08-07 | 인디비어 유케이 리미티드 | 도파민 d3 수용체 길항제 화합물 |
-
2015
- 2015-10-30 KR KR1020177014318A patent/KR20170090422A/ko unknown
- 2015-10-30 JP JP2017523340A patent/JP2017532364A/ja active Pending
- 2015-10-30 MX MX2017005484A patent/MX2017005484A/es unknown
- 2015-10-30 CA CA2964103A patent/CA2964103C/fr active Active
- 2015-10-30 SG SG11201702982UA patent/SG11201702982UA/en unknown
- 2015-10-30 CN CN201580071094.4A patent/CN107108597B/zh active Active
- 2015-10-30 WO PCT/GB2015/053272 patent/WO2016067043A1/fr active Application Filing
- 2015-10-30 RU RU2017118562A patent/RU2017118562A/ru not_active Application Discontinuation
- 2015-10-30 ES ES15790229T patent/ES2883831T3/es active Active
- 2015-10-30 DK DK15790229.7T patent/DK3212637T3/da active
- 2015-10-30 MA MA040858A patent/MA40858A/fr unknown
- 2015-10-30 US US15/522,863 patent/US10000477B2/en active Active
- 2015-10-30 NZ NZ731118A patent/NZ731118A/en unknown
- 2015-10-30 EP EP15790229.7A patent/EP3212637B1/fr active Active
- 2015-10-30 AU AU2015340308A patent/AU2015340308B2/en active Active
-
2017
- 2017-04-13 IL IL251725A patent/IL251725B/en active IP Right Grant
- 2017-04-19 ZA ZA2017/02765A patent/ZA201702765B/en unknown
-
2018
- 2018-05-09 US US15/975,466 patent/US10239870B2/en active Active
-
2019
- 2019-01-29 US US16/261,206 patent/US10654842B2/en active Active
-
2020
- 2020-07-30 IL IL276400A patent/IL276400A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DK3212637T3 (da) | 2021-07-12 |
US10239870B2 (en) | 2019-03-26 |
BR112017009042A2 (pt) | 2018-07-03 |
US20170334895A1 (en) | 2017-11-23 |
IL276400A (en) | 2020-09-30 |
ES2883831T3 (es) | 2021-12-09 |
EP3212637B1 (fr) | 2021-06-02 |
JP2017532364A (ja) | 2017-11-02 |
CN107108597A (zh) | 2017-08-29 |
ZA201702765B (en) | 2019-05-29 |
AU2015340308B2 (en) | 2019-09-19 |
US10000477B2 (en) | 2018-06-19 |
RU2017118562A (ru) | 2018-11-30 |
RU2017118562A3 (fr) | 2019-05-28 |
AU2015340308A1 (en) | 2017-05-11 |
MX2017005484A (es) | 2017-10-20 |
WO2016067043A1 (fr) | 2016-05-06 |
US20180282318A1 (en) | 2018-10-04 |
CA2964103A1 (fr) | 2016-05-06 |
IL251725A0 (en) | 2017-06-29 |
IL251725B (en) | 2020-08-31 |
US10654842B2 (en) | 2020-05-19 |
US20190300514A1 (en) | 2019-10-03 |
CA2964103C (fr) | 2022-08-30 |
EP3212637A1 (fr) | 2017-09-06 |
SG11201702982UA (en) | 2017-05-30 |
NZ731118A (en) | 2023-05-26 |
KR20170090422A (ko) | 2017-08-07 |
CN107108597B (zh) | 2020-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3368060T3 (da) | Glugacon-receptor-agonister | |
DK3440105T3 (da) | T-cellereceptorer | |
DK3440106T3 (da) | T-cellereceptorer | |
DK3494133T3 (da) | Anti-kras-g12d-t-cellereceptorer | |
DK3628687T3 (da) | Kimære bcma-antigenreceptorer | |
CL2016002129A1 (es) | Compuestos de azolina | |
MA40858A (fr) | Composés antagonistes des récepteurs d3 à la dopamine | |
DK3298027T3 (da) | Anthelmintiske depsipeptidforbindelser | |
DK3143037T3 (da) | Alpha4beta7-integrin-thioether-peptidantagonister | |
BR112016029361A2 (pt) | novos compostos substituídos por halogênio | |
DK3194411T3 (da) | Nukleotidanaloger | |
DK3189043T3 (da) | Terapeutiske forbindelser som hæmmere af orexin-1-receptoren | |
DK3331886T3 (da) | Dopamin-d3-receptorantagonister med en bicyclo-del | |
BR112017002508A2 (pt) | novos compostos substituídos com halogênio | |
DK3197890T3 (da) | Disubstituerede diaryloxybenzoheterodiazolforbindelser | |
CL2016002165A1 (es) | Compuestos de aminocarbonilcarbamato | |
IL247143B (en) | A new use of agonistic compounds for the sigma-1 receptor | |
DK3334721T3 (da) | Cgrp-receptorantagonister | |
DK3191466T3 (da) | Azetidinyloxyphenylpyrrolidinforbindelser | |
DK3183242T3 (da) | Substituerede bicykliske forbindelser | |
MA49708A (fr) | Dérivés de dihétérocycle liés à cycloalkyle | |
BR112017002509A2 (pt) | novos compostos substituídos com halogênio | |
DK3362446T3 (da) | Dopamin-d3-receptorantagonister med en morpholindel | |
DK3310756T3 (da) | Thromboxanreceptorantagonister | |
DK3142666T3 (da) | 5-HT4-receptoragonist til gastroparese |